Expression and Purification of the Spike Protein (S) of Covid19 Virus for Diagnostic Purposes and Production of Live Attenuated Viral Vaccines Dr. Christopher Richardson Dalhousie University, IWK Health Total Project Value: $25,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, spike protein, immune diagnostic, discovery sciences, vaccine
- Funded by Research Nova Scotia
- Total publications:0 publications
Grant search
Key facts
Disease
COVID-19start year
2021Funder
Research Nova ScotiaPrincipal Investigator
Dr. Christopher RichardsonResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
COVID-19, spike protein, immune diagnostic, discovery sciences, vaccine